Videos
Dr. Jesus Berdeja on a Phase 1 Talquetamab Study
What is the background of this study?
New immunotherapy targets in multiple myeloma are needed as patients continue to relapse. The orphan receptor GPRC5D is expressed on malignant plasma cells in myeloma.…
Videos
Dr. Paula Rodriguez-Otero on a Pooled Analysis of the O-12-MI and HORIZON Studies
What is the background of this study?
Melphalan flufenamide (melflufen) is a first-in-class peptide-drug conjugate (PDC) that leverages aminopeptidases and rapidly releases alkylating agents…
Videos
Dr. Roman Hajek on the ANCHOR Study
What is the background of this study?
The development of resistance to standard treatments for relapsed refractory multiple myeloma (RRMM) highlights the need for novel therapies. Melphalan flufenamide (melflufen) is a first-in-class…
Videos
Dr. Larry D. Anderson Jr. on the KarMMa Trial
What is the background of this study?
Patients (pts) with relapsed refractory mutiple myeloma (RRMM) previously exposed to immunomodulatory agents, proteasome inhibitors (PIs), and CD38 antibodies (mAbs) have poor…
Event
My name is Andy Sninsky, sometimes known as “That Crazy Guy on a Bike”. Since 2011, I have cycled more than 25,000 miles throughout the U.S., Europe, and lands down under to raise awareness of Multiple Myeloma.
How does that work, you ask? I am riding a…
News Article
As of October 19, 2021:
The Healthwell Foundation has available funds for their co-pay assistance program. To learn if you qualify and how to apply, visit this …
Videos
What can myeloma patients do to strengthen their immune system?
In this episode, Dr. Brian G.M. Durie discusses the best diet and lifestyle habits for myeloma patients to help boost their immune system.
The BOTTOM LINE:
Choose whole foods with a focus on a Mediterranean-style diet.…
Event
This International Myeloma Foundation Regional Community Workshop offers myeloma patients and caregivers up-to-the-minute information about multiple myeloma. Topics include an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on…
Audio
IMF Chairman of the Board Dr. Brian G.M. Durie interviews Alexis Stamatis, an internationally renowned novelist, poet, and playwright. Diagnosed with myeloma in 2012, Stamatis applies his writer’s perspective to coping with the disease. He says, “I think that half a century from now, people will…
News Article
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, has announced that the U.S. Food and Drug…
News Article
On Sunday, May 23, 2021, Lori Klein and Betsy Mencher held the first online cooking class, and it was a huge success! Both of them have a strong connection to the myeloma community and have held successful fundraisers in the past. At the beginning of the year, I was contacted by Lori to let…
Videos
What COVID-19 vaccine is best for myeloma patients?
In this episode, Dr. Brian G.M. Durie discusses the several COVID-19 vaccines available globally and which is best for myeloma patients.
The BOTTOM LINE:
Discuss your situation carefully with your doctor. Get vaccinated with whichever…
Audio
Listen to Multiple Myeloma Patient Deidra Jones Share Her Story
Deidra Jones talks about her myeloma diagnosis, coping with both congestive heart failure and multiple myeloma, undergoing treatment with Velcade and a clinical trial with venetoclax, as well as becoming an IMF Support Group…
News Article
The International Myeloma Foundation (IMF) has begun a multiyear, multidisciplinary initiative, M-Power Charlotte, which is designed to promote the early diagnosis and treatment of myeloma in the Black community. The IMF is working with Atrium Health Levine Cancer Institute’s Disparities &…
Videos
What is the current COVID-19 rate of infection within the myeloma community?
In this episode, Dr. Brian G.M. Durie discusses the level of COVID-19 infections within the myeloma community and if patients can safely visit the clinic to receive treatment.
The BOTTOM LINE:
Despite a…
News Article
iStopMM Study: Pioneering Screening for Myeloma’s Precursor, MGUS
The Iceland Screens, Treats, or Prevents Multiple Myeloma study (iStopMM) is the first to evaluate the benefits and harms of screening for MGUS, a precursor to the disease.
80,759…
Audio
Listen to Multiple Myeloma Patient Jeff O'Donnell Share His Story
Jeff O'Donnell talks about his myeloma diagnosis, undergoing an autologous stem cell transplant, alleviating side effects with the use of doctor-prescribed CBD-products, and his treatment with Darzalex Faspro®.
In this Myeloma…
Videos
Do Steroids Like Dexamethasone Increase Myeloma Treatment Efficacy?
Dr. Brian Durie discusses if steroids like dexamethasone are required when treating multiple myeloma and why steroids are used as part of treatment.
The BOTTOM LINE:
The use of steroids improves the effectiveness of…
Videos
A Virtual Webinar on How to Optimize and Protect Your Immune System Using a Nutrition Based Approach
Watch this webinar to understand how a healthy diet can help fortify your immune system.
We are all hearing about how critical the immune system is for our overall health. What is the immune…
Videos
Darzalex Faspro Is the Subcutaneous Version of the Drug Darzalex
How Darzalex Faspro can improve the quality of life for patients living with multiple myeloma.
In this video, Dr. Joseph Mikhael (IMF Chief Medical Officer) and Kimberly Noonan, DNP, RN, ANP-BC, AOCN® (a member of IMF's Nurse…
Videos
Myeloma Protein Levels in the Blood and the Amount of Myeloma in the Body
In this episode, Dr. Brian G.M. Durie discusses how the level of myeloma protein found in the blood corresponds to the amount of myeloma found in the body.
The BOTTOM LINE:
Discuss your situation with your…
Videos
Virtual Myeloma Webinar on Promising New Therapies For Myeloma Patients Myeloma Experts From Across the Nation Share News on CAR T-Cell Therapy, Provide Updates on the COVID-19 Vaccines, and More. This IMF Patient & Family Webinar features exciting, late-breaking news about CAR T-cell…
Audio
Listen to Multiple Myeloma Patient Diane Hunter Share Her Story
Diane Hunter discusses receiving her myeloma diagnosis, disparities in healthcare, and how she has coped during the pandemic.
In April of 2016, Diane went in for her annual checkup with her endocrinologist. While going over her…
Audio
.accordion {
box-sizing: border-box;
display: flex;
font-family: Arial, Helvetica, sans-serif;
overflow: hidden;
width: 100%;
}
.accordion-select {
cursor: pointer;
margin: 0;
opacity: 0;
z-index: 1;
}
.accordion-title {
position: relative…
Videos
How Soon Should Myeloma Patients Restart Therapy Post COVID-19?
Continuing his COVID-19 FAQ, Dr. Brian G.M. Durie advises when patients should restart their myeloma treatment after recovering from the COVID-19 virus.
The BOTTOM LINE:
If possible, delay…
Event
We are all hearing about how critical the immune system is for our overall health. What is the immune system and how can we protect it? Can nutrition improve your immune system for better defense against diseases, bacteria, or viruses? Can supplements help?
Join us to get answers to these…
Videos
How Can Testing for COVID-19 Antibodies Help Myeloma Patients Stay Safe?
Continuing his COVID-19 FAQ, myeloma expert Dr. Brian G.M. Durie discusses if patients should consider getting an antibody test to understand their level of protection against COVID-19.
The…
Page
ABECMA® (idecabtagene vicleucel, also known as “ide-cel”) is the first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell immunotherapy approved by the U.S. Food and Drug Administration (FDA) in March 2021 for the treatment of adult patients with relapsed…
Support Group
Videos
Virtual Multiple Myeloma Workshop Focusing on Communities in KansasWhat Is Included in This Virtual Myeloma Workshop?This International Myeloma Foundation Regional Community Workshop is a virtual workshop that offers myeloma patients and caregivers up-to-the-minute information about multiple…
Videos
Could Getting the Vaccine Trigger Myeloma Progression?
Continuing his COVID-19 FAQ, myeloma expert Dr. Brian G.M. Durie discusses if patients should be concerned about disease progression brought on by the vaccination.
The BOTTOM LINE:
There is no…
Videos
How the Immune System Can Be Used To Fight MyelomaIMF Chief Medical Officer Dr. Joseph Mikhael discusses how the immune system can be used to fight multiple myeloma.In particular, he explains that BCMA is found on the surface of myeloma cells and thus makes an excellent target for treatment.…
Videos
What myeloma patients can do to de-stress and nurture resilience.
Continuing his COVID-19 FAQ, myeloma expert Dr. Brian G.M. Durie discusses the importance of staying connected and boosting resilience while staying safe during the pandemic.
The BOTTOM LINE: …
News Article
LOS ANGELES, CA, April 6, 2021— Amid the pandemic, the team at the International Myeloma Foundation remained steadfast about its goals: Myeloma Action Month (MAM) in March 2021 would inspire the myeloma community and beyond to take action and create awareness about this incurable…
Page
Visit DARZALEX® (daratumumab) for more information about this drug’s original formulation and its intravenous (IV, into the vein) administration. What Is Darzalex Faspro?Darzalex Faspro® is a newer formulation of Darzalex that is administered as an…
Page
What Is Blenrep?Blenrep® (belantamab mafodotin-blmf) is an antibody-drug conjugate (ADC), the first in a new class of treatments for myeloma. Blenrep is the combination of a monoclonal antibody (mAb) that binds to a specific receptor on the surface of myeloma cells called B-cell maturation antigen…
Audio
The “A Day in the Life” podcast from the International Myeloma Foundation features messages of hope and resilience for myeloma patients, caregivers, and their loved ones. This episode features an interview with Jack Aiello, a 26-year multiple myeloma survivor, father of 3, and grandfather of four.…
Videos
How Do The COVID-19 Variants Impact Myeloma Patients?
Continuing his COVID-19 FAQ, myeloma expert Dr. Brian G.M. Durie discusses how the emerging COVID-19 variants impact myeloma patients and how to stay safe.
The BOTTOM LINE:
It is recommended to…
News Article
Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the European Commission (EC) has granted conditional marketing authorization for NEXPOVIO (selinexor), the Company's first-in-class, oral Selective Inhibitor…
Videos
(click on the image above to view the video)Virtual Multiple Myeloma Workshop Focusing on Communities in San Diego, CAWhat Is Included in This Virtual Myeloma Workshop?This International Myeloma Foundation Regional Community Workshop offers myeloma patients and caregivers up-to-the-minute…
News Article
Los Angeles, CA, March 26, 2021—Calling it "a win for patients," the International Myeloma Foundation (IMF) welcomed…
Videos
What Is Ide-Cel?
In this episode, myeloma expert Dr. Brian G.M. Durie discusses ide-cel treatment and how it can be used in treating patients with multiple myeloma.
The BOTTOM LINE:
Ide-cel is a promising new therapy where a third of patients reported an average treatment-free…
Event
The International Myeloma Foundation will co-host a session at the 8th Annual Eurasian Hematology Oncology Virtual Summit on April 17-18, 2021.
This event is open for registration to healthcare professionals in the myeloma community, however, it is not open to the general public…
Event
Last year, to celebrate my 60th birthday, Huckleberry (an Australian Cattle dog of strong character and questionable intelligence) and I began hiking the Appalachian Trail to raise money for two great causes, The International Myeloma Foundation and The CCHS…
Videos
A Virtual Myeloma Workshop On Disparities in Myeloma Care and Survival
Learn about multiple myeloma, a disease more than twice as common in people of African descent as in whites.
This M-Power Charlotte virtual myeloma workshop includes…
Page
Multiple myeloma can impact your immune system, making you vulnerable to infections. But there is potential for your immune system to fight back. Immunotherapy offers a way to strengthen your defenses and target myeloma cells. By boosting your body's natural defenses, these therapies provide a…
Videos
Is the COVID-19 Vaccine Safe for Myeloma Patients?
Continuing his COVID-19 FAQ series, Dr. Brian G.M. Durie advises myeloma patients on the importance of being vaccinated against COVID-19 (coronavirus).
The BOTTOM LINE:
Getting vaccinated against…
Event
This International Myeloma Foundation Regional Community Workshop is a virtual workshop, set in an engaging environment, that offers myeloma patients and caregivers up-to-the-minute information about multiple myeloma. Topics include an introduction to myeloma (Myeloma 101), upfront treatments at…